Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.

Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer. 2004 Dec 15; 101(12):2788-801.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Bone Marrow
Central Nervous System Neoplasms
Cyclophosphamide
Dexamethasone
Doxorubicin
Drug Administration Schedule
Follow-Up Studies
Humans
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prognosis
Remission Induction
Risk
Survival Analysis
Vincristine

authors with profiles

CARLOS E BUESO-RAMOS
HAGOP M KANTARJIAN
JORGE E CORTES